Alamar Biosciences, Inc.
ALMR
$20.76
$0.562.75%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -21.33M | -7.66M | |||
| Total Depreciation and Amortization | 1.17M | 888.00K | |||
| Total Amortization of Deferred Charges | 67.00K | 42.00K | |||
| Total Other Non-Cash Items | 11.13M | 723.00K | |||
| Change in Net Operating Assets | -11.39M | -7.06M | |||
| Cash from Operations | -20.35M | -13.07M | |||
| Capital Expenditure | -600.00K | -554.00K | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -178.00K | 17.57M | |||
| Cash from Investing | -778.00K | 17.02M | |||
| Total Debt Issued | 56.50M | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 1.80M | 243.00K | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -2.54M | -- | |||
| Cash from Financing | 55.76M | 243.00K | |||
| Foreign Exchange rate Adjustments | -52.00K | 133.00K | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 34.58M | 4.33M | |||